Recently, Chatterjee et al. showed that TGF-β increase the expression of PD-L1 on the exosomes secreted by breast cancer cells in a dose-dependent manner, while blocking exosome release and inhibiting the expression of TGF-β reduced the tumor burden and enhanced T cell toxicity [115]. Here, CD274 is linked to breast cancer.